News > Page 56

• 

  Revolutionary Approach for Treating Immune Disorders Unveiled at 2024 BIO International

  5/23/2024
• 

  FDA Approves Phase III Trial, Offering New Hope for Advanced Prostate Cancer Patients

  5/23/2024
• 

  Localized Drug Delivery: A New Hope for Fighting KRAS+ Tumors

  5/23/2024
• 

  Breakthrough Treatment for Hidradenitis Suppurativa: Phase 3 Trials Show Promising Results

  5/23/2024
• 

  New Phase 3 Study Highlights Eplontersen's Benefits for Nerve Damage

  5/23/2024
• 

  Servier's Bold Move Against Cancer: New Findings at ASCO 2024

  5/23/2024
• 

  Revolutionary Immune Therapy: Bionoxx's New Approach to Fighting Cancer

  5/23/2024
• 

  New Breakthrough in Stem Cell Therapy for Graft vs. Host Disease

  5/23/2024
• 

  Revolutionizing Lung Disease Predictions with AI: Brainomix's New Advances

  5/23/2024
• 

  FDA Approves Advanced Digital Pathology Platform: HALO AP Dx

  5/23/2024